As a pioneer in the field of lipidomics, Lipotype not only provides lipidomic analysis services to customers but also contributes to science through carrying out its own research. On March 3rd, a study titled “Lipid profiling can predict risk of diabetes, cardiovascular disease decades before onset” from Dr. Christian Lauber and colleagues has been published in the open-access journal PLOS Biology. This longitudinal study demonstrates that lipidomic profiling in the blood can predict risk for type 2 diabetes (T2D) and cardiovascular disease (CVD). Such a finding provides a basis for the question of what efforts should be made to prevent T2D and CVD, as well as suggests blood lipidome is a reliable indicator of a person’s health status.
Find out more about the publication in the link below.
Follow us on LinkedIn, Twitter, Instagram, Facebook or YouTube and subscribe to our newsletter to stay updated on lipids and lipidomics!
